CVS Health (CVS)
(Delayed Data from NYSE)
$66.63 USD
-0.22 (-0.33%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $66.63 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
A Value D Growth C Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$66.63 USD
-0.22 (-0.33%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $66.63 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
A Value D Growth C Momentum B VGM
Zacks News
Will Central Banks Start to Care About Fundamentals?
by John Blank
Macro-data has been much stronger than expected.¿¿¿¿¿¿ Still, the only thing that matters is NOT whether stock traders (or pundits) take note of strong data. It is whether the Fed and other major central banks care.
Markets Up to Start Another Busy Week
by Mark Vickery
With Q1 earnings season continuing to unfold favorably (for the most part), investors look to enjoy a healthy Q2, as well.
Is a Beat in the Cards for CVS Health (CVS) in Q1 Earnings?
by Zacks Equity Research
Given the increasing number of walk-in-clinical appointments and patient visits, CVS Health (CVS), which has a huge PBM client base, is expected to have seen a sequential rebound in Q1 revenues.
CVS Health (CVS) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, CVS Health (CVS) closed at $75.75, marking a -0.39% move from the previous day.
CVS Health (CVS) Stock Moves -0.17%: What You Should Know
by Zacks Equity Research
In the latest trading session, CVS Health (CVS) closed at $75.75, marking a -0.17% move from the previous day.
The Zacks Analyst Blog Highlights: Home Depot, Toyota, International Business Machines, Merck and CVS Health
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Home Depot, Toyota, International Business Machines, Merck and CVS Health
Top Research Reports for Home Depot, Toyota & IBM
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including The Home Depot (HD), Toyota Motor (TM), and International Business Machines (IBM).
CVS Health (CVS) Gains As Market Dips: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed the most recent trading day at $74.46, moving +0.53% from the previous trading session.
Magellan (MGLN) Expands in Precision Oncology With Trapelo
by Zacks Equity Research
Magellan Health (MGLN) partners Trapelo Health to offer an all-inclusive approach to value-based care in the innovative arena of precision oncology treatments.
CVS Health (CVS) Extends COVID-19 Antibody Testing Nationwide
by Zacks Equity Research
CVS Health's (CVS) antibody test detects for previous infection to COVID-19 and provides results within 15 minutes.
CVS Health (CVS) Gains But Lags Market: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed the most recent trading day at $75.04, moving +0.7% from the previous trading session.
Why the Earnings Surprise Streak Could Continue for CVS Health (CVS)
by Zacks Equity Research
CVS Health (CVS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
CVS Health (CVS) Stock Moves -0.29%: What You Should Know
by Zacks Equity Research
In the latest trading session, CVS Health (CVS) closed at $76.08, marking a -0.29% move from the previous day.
CVS Health (CVS) Gains As Market Dips: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed the most recent trading day at $73.21, moving +1.82% from the previous trading session.
Why Is CVS Health (CVS) Up 1.8% Since Last Earnings Report?
by Zacks Equity Research
CVS Health (CVS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
CVS Health (CVS) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed at $74.01 in the latest trading session, marking a -1.41% move from the prior day.
CVS Health (CVS) Extends COVID-19 Testing in Massachusetts
by Zacks Equity Research
CVS Heath's (CVS) antibody testing to be available in nearly 60 MinuteClinic locations and cost $38.
CVS Health (CVS) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, CVS Health (CVS) closed at $72.35, marking a -0.48% move from the previous day.
Zacks Industry Outlook Highlights: CVS Health, Walgreen Boots, Herbalife, Rite Aid and Amazon
by Zacks Equity Research
Zacks Industry Outlook Highlights: CVS Health, Walgreen Boots, Herbalife, Rite Aid and Amazon
Magellan's (MGLN) Q4 Earnings Miss Estimates, Decline Y/Y
by Zacks Equity Research
Magellan Health's (MGLN) results reflect a decline in earnings and revenues due to lower contribution from Healthcare and Pharmacy Management units.
3 Pharmacies & Drugstore Stocks to Watch Amid COVID-19 Resurgence
by Urmimala Biswas
Despite severe COVID-19 challenges, higher demand for telemedicine and federal collaborations for vaccine rollout are likely to lend support to the Zacks Retail - Pharmacies and Drug Stores industry. HLF is well positioned to gain now while CVS and RAD hold huge prospects.
The Zacks Analyst Blog Highlights: Berkshire Hathaway, Walmart, Home Depot, CVS Health and Booking Holdings
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Berkshire Hathaway, Walmart, Home Depot, CVS Health and Booking Holdings
Top Research Reports for Berkshire Hathaway, Walmart & Home Depot
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Berkshire Hathaway (BRK.B), Walmart (WMT) and Home Depot (HD).
CVS Health (CVS) Q4 Earnings Top Estimates but Decline Y/Y
by Zacks Equity Research
The pandemic affects CVS Health's (CVS) fourth-quarter revenues in the Pharmacy Services segments as new therapy prescriptions reduce due to lower provider visits.
Magellan Health (MGLN), Wellth Tie Up on Behavioral Change
by Zacks Equity Research
Magellan Health (MGLN) initiates a pilot program with Wellth to improve medication adherence and the general health of its members.